Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
What we know is this: GLP1s can quiet the noise
The retatrutide phase 2 data, showing up to approximately 24.2% mean weight loss at 48 weeks with the 12 mg dose, suggests that the triple agonist mechanism may offer incremental benefit over dual agonism
Inorg Biochem
In a dedicated sleep apnea trial, tirzepatide reduced the apnea-hypopnea index (AHI) by 25.3 events per hour at 52 weeks compared to 5.3 with placebo
Undermining glutaminolysis bolsters chemotherapy while NRF2 promotes chemoresistance in KRAS-driven pancreatic cancers
US$ 28.43
US$ 28.12
US$ 23.30
US$ 25.66
